Tiziana Life Sciences Files 6-K Report

Ticker: TLSA · Form: 6-K · Filed: Apr 1, 2026 · CIK: 0001723069

Tiziana Life Sciences Ltd 6-K Filing Summary
FieldDetail
CompanyTiziana Life Sciences Ltd (TLSA)
Form Type6-K
Filed DateApr 1, 2026
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-issuer, press-release

TL;DR

Tiziana Life Sciences filed a 6-K on April 1, 2026, with a press release. Nothing major revealed.

AI Summary

Tiziana Life Sciences Ltd. filed a Form 6-K on April 1, 2026, reporting as a foreign issuer. The filing includes a press release dated April 1, 2026, and associated graphic files. The company's mailing and business address is in London, England.

Why It Matters

This filing indicates ongoing reporting activity for Tiziana Life Sciences Ltd., which is relevant for investors tracking the company's regulatory compliance and disclosures.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that primarily contains a press release and does not appear to disclose significant new financial or operational information.

Key Players & Entities

  • Tiziana Life Sciences Ltd (company) — Filer
  • April 1, 2026 (date) — Filing Date and Press Release Date

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers which provides information that the issuer would be required to disclose to any security holders pursuant to the laws of the issuer's home country or jurisdiction of incorporation or organization, or that it would be required to file with or submit to any stock exchange on which the issuer has securities listed or traded.

What documents are included in this specific 6-K filing?

This filing includes a report of foreign private issuer, a press release dated April 1, 2026, and associated graphic files.

What is Tiziana Life Sciences Ltd.'s business address?

Tiziana Life Sciences Ltd.'s business address is 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB.

What is the SIC code for Tiziana Life Sciences Ltd?

The SIC code for Tiziana Life Sciences Ltd is 2834, which corresponds to Pharmaceutical Preparations.

When was this filing accepted by the SEC?

This filing was accepted by the SEC on April 1, 2026, at 07:00:01.

Filing Stats: 324 words · 1 min read · ~1 pages · Grade level 13.9 · Accepted 2026-04-01 07:00:01

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TIZIANA LIFE SCIENCES LTD Date: April 1, 2026 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Tiziana Life Sciences LTD Press Release, dated April1, 2026 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.